Abstract
Objective: To investigate the cardio-protective effects of Corocalm on acute myocardial ischemia in rats, and to explore its possible therapeutic mechanisms.Methods: The acute ischemic model was prepared by ligating the left anterior descending (LAD) coronary artery in rats. The animals were divided into 6 groups, 8 in each group. The sham operated group underwent heart exposure without ligation and were treated with normal saline 3 ml/kg, while the other 5 groups, the model groups, consisted of acceptable acute ischemic model rats and were also treated with normal saline, with the Guanxin Capsule (GXC) group treated with refined GXC, 600 mg/kg, the low and high dose Corocalm groups treated with 85 mg/kg and 340 mg/kg of Corocalm respectively, and the Diltiazem group, treated with Diltiazem 5 mg/kg, with all the tested drugs prepared with normal saline into equal volume (3 ml/kg) and administrated once via duodenum 10 min before ligation. Myocardial infarction area was determined by the quantitative histological assay with nitroblue tetrazolium (N-BT) stain. And the levels of creatine phosphokinase (CK), lactate dehydrogenase (LDH), malondialdehyde (MDA) content, and the activity of superoxide dismutase (SOD) in serum were measured by biochemical assay and spectrophotometry respectively. Besides, the blood viscosity in another 50 rats was determined, who received for 7 successive days oral administration with different concentration of Corocalm or aspirin.Results: It showed that low and high dose Corocalm could significantly reduce the infarction area, inhibit the increase of serum CK, LDH activity and MDA content, and enhance the SOD activity after ischemia/reperfusion. The whole blood viscosity at different shear rates in rats treated with high dose Corocalm was significantly lower than those treated with normal saline (P < 0.05).Conclusion: Corocalm has favourable protective effects on heart in ischemic condition, the effect of which might be through its actions in inhibiting CK and LDH activity, scavenging oxygen free radicals, and lowering blood viscosity.
Similar content being viewed by others
References
Lei XL, Chiou GC. Cardiovascular pharmacology of Panax notoginseng (Burk) F.H. Chen and Salvia miltiorrhiza. Am J Chin Med 1986;14: 145–152.
Liebgott T, Miollan M, Berchadsky Y, et al. Complementary cardioprotective effects of flavonoid metabolites and terpenoid constituents of Ginkgo biloba extract (EGb 761) during ischemia and reperfusion. Basic Res Cardiol 2000; 95(5): 368–377.
Han X, Liu JX, Ma XB, et al. Effects of Shuangshen tongguan (SSTG) on TNF-α, ICAM-1 during myocardial ischemia-reperfusion injury. China J Chin Materia Med 2004;29 (11): 1073–1075.
Liu JX, Shang XH, Fu JH, et al. Effects of recombinant staphylokinase on coronary thrombosis in Chinese experimental miniature swine. Acta Pharmacol Sin 2002;23(6): 509–515.
Panteghini M, Apple FS, Christenson RH, et al. Use of biochemical markers in acute coronary syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. International Federation of Clinical Chemistry. Clin Chem Lab Med 1999;37(6): 687–693.
Chen KJ. The therapeutic effect of purified coronary heart II tablets on 112 cases of angina pectoris by double blind method. Chin J Cardiol 1982;10(2): 85–89.
Zhao BL, Jiang W, Zhao Y, et al. Scavenging effects of salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury. Biochem Mol Biol Int 1996;38(6): 1171–1182.
DeClerck F, Janssen PA. 5-Hydroxytryptamine and thromboxane A2 in ischemic heart disease. Blood Coagul Fibrinolysis 1990;1(2): 201–210.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the National Key Technology Programs Foundation during the 9th Five-year Plan Period (No. 96-903-01-02)
Rights and permissions
About this article
Cite this article
Jian-xun, L., Xin-zhi, L., Xiao-bin, M. et al. Cardio-protective effects of Corocalm on acute myocardial ischemia/reperfusion injury in rats. Chin. J. Integr. Med. 12, 199–202 (2006). https://doi.org/10.1007/BF02836522
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02836522